MannKind (NSDQ:MNKD) said today that it inked a deal with a group of unnamed investors for a registered direct offering of 10,166,600 shares of the company’s common stock for $6.00 apiece.
The $61 million offering is slated to close later this week.
Get the full story at our sister site, Drug Delivery Business News.
The post MannKind inks $61m direct offering of common stock appeared first on MassDevice.